Latest Emmaus Medical Inc. Stories
TORRANCE, Calif., Jan. 7, 2014 /PRNewswire/ -- Emmaus Medical, Inc.
LOS ANGELES, May 18 /PRNewswire/ -- Emmaus Medical, Inc., the privately-held pharmaceutical company developing and bringing to market a promising new treatment for sickle cell disease, announced today that Henry (Hank) McKinnell Jr., PhD, has joined the board of directors. Dr.
By Melissa Evans After years of clinical trials and research, Dr. Yutaka Niihara came up with a treatment for sickle cell anemia that was so simple he almost didn't believe it.
- Stoppage; cessation (of labor).
- A standing still or idling (of mills, factories, etc.).